Characterization of a novel AB5 cytotoxin

新型 AB5 细胞毒素的表征

• 批准号: 7327767
• 负责人: Adrienne W Paton
• 金额: $ 26.49万
• 依托单位: UNIVERSITY OF ADELAIDE
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-15 至 2011-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7327767
• 关键词: Affect; Animal Model; Antibodies; Apoptosis; Bacteria; Bacterial Toxins; Binding; Biology; Bioterrorism; Blood; Blood Cells; Categories; Cell Death; Cell Line; Cell surface; Cells; Cellular biology; Child; Cholera; Cholera Toxin; Class; Collaborations; Computer Simulation; Confocal Microscopy; Coupled; Crystallization; Crystallography; Cultured Cells; Cytosol; Cytotoxin; Data; Development; Disease; Disease Outbreaks; Dose; Electron Microscopy; Emerging Communicable Diseases; Endoplasmic Reticulum; Escherichia coli; Eukaryotic Cell; Family; Fluorescence; Foundations; Funding; Future; Genes; Glycolipids; Goals; Harvest; Hemolytic-Uremic Syndrome; Histologic; Histopathology; Housing; Human; Immunohistochemistry; In Vitro; Institution; Investigation; Knock-out; Knowledge; Label; Lead; Life; Microscopy; Modeling; Molecular; Molecular Chaperones; Mus; Mutate; Names; Nature; Neurologic Manifestations; Oral; Organ; Outcome; Pathogenesis; Pathology; Pathway interactions; Pertussis Toxin; Pharmaceutical Preparations; Plasmids; Positioning Attribute; Proteins; Proteomics; Publishing; Range; Reagent; Recombinants; Reporting; Research; Research Personnel; Resistance; Resolution; Role; Serine Protease; Shiga Toxin; Specificity; Stress; Structure; Targeted Toxins; Testing; Therapeutic; Therapeutic Agents; Time; Tissues; Toxic effect; Toxin; Vaccines; Vero Cells; Virulence Factors; Western Blotting; X-Ray Crystallography; base; cell injury; cellular targeting; cytotoxic; cytotoxicity; design; gastrointestinal; gastrointestinal infection; gene cloning; glycolipid receptor; holotoxins; human disease; in vivo; insight; laboratory facility; mouse model; mutant; novel; pathogen; programs; receptor; response; retrograde transport; small molecule; three dimensional structure; tissue tropism; tool; trafficking; uptake

We have recently discovered a novel "Subtilase cytotoxin" produced by a strain of Shiga toxigenic Escherichia coli (a category B Priority Pathogen) that was responsible for an outbreak of hemolytic uremic syndrome (HUS). It belongs to a new class of AB5 cytotoxins, because its A subunit has distinct enzymic activity and it has no sequence similarity with any of the other AB5 toxin families (cholera, Shiga and pertussis toxins). Subtilase cytotoxin is extraordinarily cytotoxic for cultured cells and is lethal for mice (with histopathology similar to that of HUS). Apart from its possible role in severe human disease, it is a potential bioterrorism agent which could have global impact. The long-term objective of this response to PA-04-119 is complete structural and functional characterization of the emerging toxin. Its Specific Aims are: 1. Elucidation of the molecular basis for cytotoxicity. A subunit Subtilase-like serine protease activity is essential for cytotoxicity, and preliminary data indicate that the ER chaperone BiP is a key cellular target for the toxin. In this Aim, we will continue our investigation of the molecular basis for cytotoxicity by examining the downstream consequences of BiP cleavage, including whether this results in ER stress and apoptosis. 2. Investigation of toxin trafficking in target cells. We hypothesize that after binding to the cell surface, the toxin must undergo retrograde transport to the ER in order to exert its toxic effects. Intracellular toxin trafficking will therefore be examined by co-localization of labelled toxin with cellular compartmental markers using confocal microscopy. 3. Examination of tissue tropism and in vivo effects of the toxin. The distribution of toxin receptors in mouse tissues and trafficking of labelled toxin in vivo will be examined using fluorescence, confocal and electron microscopy. The direct contribution of Subtilase cytotoxin to the pathogenesis of STEC disease will also be investigated in a mouse model. 4. Determination of the 3Dstructure of the toxin. X-ray crystallography and computer modelling will be used to solve the 3D structure. Relevance: This project will provide essential information on the basic biology of this emerging toxin, particularly its structure and the mechanism whereby it damages cells and tissues. This will provide a foundation for the future development of countermeasures including therapeutic agents and vaccines.

我们最近发现了一种新的由滋贺菌产生的“枯草杆菌酶细胞毒素 大肠埃希菌（B类优先病原体）导致溶血性尿毒症暴发 HUS综合征。它属于一类新的AB 5细胞毒素，因为它的A亚基具有独特的酶活性， 活性，并且它与任何其它AB 5毒素家族（霍乱、滋贺和 百日咳毒素）。枯草杆菌酶细胞毒素对培养的细胞具有非常强的细胞毒性，并且对小鼠（具有 组织病理学与HUS相似）。除了在严重的人类疾病中可能起作用外，它是一种潜在的 生物恐怖主义可能会产生全球影响。对PA-04-119的这一回应的长期目标 是新毒素的完整结构和功能特征。其具体目标是： 1.阐明细胞毒性的分子基础。 亚基枯草杆菌酶样丝氨酸蛋白酶活性对于细胞毒性是必不可少的，初步数据表明， ER分子伴侣BiP是毒素的关键细胞靶标。在这个目标中，我们将继续调查 通过检查BiP切割的下游后果来确定细胞毒性的分子基础，包括 这是否会导致内质网应激和细胞凋亡。 2.研究靶细胞中的毒素运输。 我们推测，在结合到细胞表面后，毒素必须经过逆行转运到ER 以发挥其毒性作用。因此，细胞内毒素运输将通过以下共定位来检查： 使用共聚焦显微镜用细胞区室标记物标记毒素。 3.毒素的组织嗜性和体内效应的检查。 将检查毒素受体在小鼠组织中的分布和标记毒素在体内的运输 使用荧光、共聚焦和电子显微镜。枯草杆菌酶细胞毒素的直接贡献 还将在小鼠模型中研究STEC疾病的发病机制。 4.毒素的三维结构测定。 X射线晶体学和计算机建模将用于解决3D结构。 相关性：本项目将提供关于这种新出现的毒素的基本生物学的重要信息， 特别是它的结构和它损害细胞和组织的机制。这将提供一个 为今后开发包括治疗剂和疫苗在内的对策奠定了基础。